Explore
Monoclonal Antibody-Directed Therapy
0 Ungluers have
Faved this Work
Login to Fave
The book deals with therapeutic monoclonal antibodies (mAbs) broadly, and relevant topics such as challenges and opportunities, next-generation antibody products, Antibody-Drug-Conjugates (ADC), bispecifics, glycosylation, and T-cell engagers are covered. Each topic has been written by leading groups around the world and the book should be of interest to researchers from both academia and industry.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 40 times via unglue.it ebook links.
- 40 - pdf (CC BY) at Unglue.it.
Keywords
- ADC
- ADME
- aggregation
- analytical characterization
- antibacterials
- antibiotics
- Antibodies
- antibody (s)
- antibody engineering
- antibody-dependent cell-mediated cytotoxicity
- antibody-drug conjugates
- bioconjugates
- bispecific antibodies
- co-formulation
- complement-dependent cytotoxicity
- developability
- Economics, finance, business & management
- effector functions
- formulation
- Glycoengineering
- Glycosylation
- high concentration
- HIV/AIDS
- immunogenicity
- Immunological Synapse
- Immunotherapy
- Industry & industrial studies
- linkers
- manufacture challenges
- Manufacturing industries
- medicine
- Nucleic acids
- oncology
- payloads
- Pharmaceutical industries
- Pharmacodynamics
- pharmacokinetics
- post-translational modifications
- prophylaxis
- site-specific conjugation
- Stability
- T-cell engagers
- therapeutic antibody
- type III secretion system
Links
DOI: 10.3390/books978-3-0365-2872-4Editions